CASI PHARMACEUTICALS, INC. (CASIF) Shareholders’ equity 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) shareholders’ equity at each fiscal year-end, per SEC filings.
-$37.3MFY2025 · since FY2020: $81.5M → -$37.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.3M | -2114.2% |
| FY2024 | $1.9M | -92.3% |
| FY2023 | $24.2M | -45.8% |
| FY2022 | $44.6M | -47.3% |
| FY2021 | $84.5M | +3.6% |
| FY2020 | $81.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice